Chronic Morphine Treatment Reduces Recovery from Opioid Desensitization
Open Access
- 1 September 2004
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 24 (35) , 7699-7706
- https://doi.org/10.1523/jneurosci.2499-04.2004
Abstract
Tolerance and dependence result from long-term exposure to opioids, and there is growing evidence linking acute receptor desensitization to these more long-term processes. Receptor desensitization encompasses a series of events leading to the loss of receptor function and internalization. This study examines the onset and recovery from desensitization in locus ceruleus neurons recorded in brain slices taken from animals that have been chronically treated with morphine. After chronic morphine treatment, desensitization was altered as follows. First, the rate of desensitization was increased. Second, recovery from desensitization was always incomplete, even after a brief (1-2 min) exposure to agonist. This contrasts with experiments in controls in which recovery from desensitization, after a brief exposure to agonist, was complete within 25 min. Finally, morphine-6-β-d-glucuronide, a metabolite of morphine that was ineffective at causing desensitization in controls, induced significant desensitization in slices from morphine-treated animals. When brain slices from controls were treated with inhibitors of PKC or monensin, agents known to compromise G-protein-coupled receptor resensitization, desensitization was increased, and recovery was significantly reduced. These results indicate that receptor resensitization maintains signaling during periods of intense and sustained stimulation. After chronic morphine treatment, desensitization is potentiated, and receptor resensitization is compromised.Keywords
This publication has 38 references indexed in Scilit:
- Differential Sorting of Human δ-Opioid Receptors after Internalization by Peptide and Alkaloid AgonistsJournal of Biological Chemistry, 2003
- Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid ReceptorsPublished by Elsevier ,2003
- Toleranzentwicklung unter Opioidgabe - Molekulare Mechanismen und klinische BedeutungAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 2003
- Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in VivoMolecular Pharmacology, 2002
- Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteinsProgress in Neurobiology, 2001
- A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to LysosomesPublished by Elsevier ,2001
- The Absence of a Direct Correlation between the Loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced μ-Opioid Receptor PhosphorylationPublished by Elsevier ,1999
- Dynamic Complexes of β2-Adrenergic Receptors with Protein Kinases and Phosphatases and the Role of GravinPublished by Elsevier ,1999
- Protein Kinase C Deficiency Blocks Recovery from Agonist-induced DesensitizationJournal of Biological Chemistry, 1996
- Chronic Morphine Administration Increases β‐Adrenergic Receptor Kinase (βARK) Levels in the Rat Locus CoeruleusJournal of Neurochemistry, 1994